International journal of radiation oncology, biology, physics
-
Int. J. Radiat. Oncol. Biol. Phys. · Sep 2009
Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience.
To analyze the effect of adjuvant chemoradiotherapy on gallbladder carcinoma. ⋯ After adjusting for the stage parameters and histologic findings, our data suggest that adjuvant chemoradiotherapy might improve OS for patients with gallbladder cancer.
-
Int. J. Radiat. Oncol. Biol. Phys. · Sep 2009
Dosimetric changes resulting from patient rotational setup errors in proton therapy prostate plans.
To evaluate the dose changes to the target and critical structures from rotational setup errors in prostate cancer patients treated with proton therapy. ⋯ Patient rotational movements of 3 degrees and 5 degrees and horizontal couch shifts of 3 degrees in prostate proton planning did not confer clinically significant dose changes to the target volumes or critical structures.
-
Int. J. Radiat. Oncol. Biol. Phys. · Sep 2009
Multicenter StudyMaximum vs. mono androgen blockade and the risk of recurrence in men with localized prostate cancer undergoing brachytherapy.
We examined whether maximum androgen blockade (MAB) is associated with a decreased recurrence risk vs. single-agent androgen suppression (monotherapy) for men undergoing brachytherapy (BT) for localized prostate cancer. ⋯ There are varied practice patterns in physicians' choice of the extent of concurrent ADT when used with brachytherapy for men with intermediate- or high-risk prostate cancer. Given a lack of demonstrated superiority from either ADT choice, both appear to be reasonable options.